Diabetic woman no longer needs insulin after single stem cell treatment — why it’s not given to everyone with diabetes ...

Long-lasting insulin takes another step forward with latest clinical trial results Scripps researcher delivers findings for Lilly drug expected to request approval from FDA soon ...

In a clinical trial led by University of Toronto researchers, an allogeneic stem cell–derived islet therapy (zimislecel) restored insulin production and ended severe hypoglycemia in adults with ...

Once-Weekly Basal Insulin Non-Inferior to Several Daily Options in Type 2 Diabetes — Insulin efsitora may potentially change the management paradigm, researcher says ...

DAS Trader, an industry leader in direct access trading technologies which offers the brokerage and trading community end-to-end electronic trading solutions, visits the Nasdaq MarketSite in Times ...

A Canadian woman with type 1 diabetes spent nearly a decade dependent on her glucose monitor and insulin shots — but after a single dose of manufactured stem cells implanted into her liver, she ...

Lilly's once-weekly insulin efsitora alfa demonstrated A1C reduction and a safety profile consistent with daily insulin in multiple Phase 3 trials ...

The Blessed Trinity Parish held a special celebration on Tuesday to commemorate the blessing of its new Trinity Bell Tower.

BOSTON (WHDH) - Researchers at Vertex Pharmaceuticals in Boston say a single infusion of stem cell-based treatment could be a permanent solution for insulin. They say it has been tested on 12 ...

Bucks County officials have filed a lawsuit against insulin makers and pharmacy benefit managers. "What we found is deeply troubling, a coordinated scheme between pharmacy benefit managers known ...